Akebia Therapeutics
AKBA
#8229
Rank
โ‚น26.10 B
Marketcap
โ‚น97.30
Share price
-4.72%
Change (1 day)
-59.36%
Change (1 year)

Market capitalization of Akebia Therapeutics (AKBA)

Market cap: โ‚น26.10 Billion

As of May 2026 Akebia Therapeutics has a market cap of โ‚น26.10 Billion. This makes Akebia Therapeutics the world's 8229th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Akebia Therapeutics from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น26.10 B-33.99%
2025โ‚น39.54 B8.35%
2024โ‚น36.49 B87.68%
2023โ‚น19.44 B121.4%
2022โ‚น8.78 B-70.16%
2021โ‚น29.43 B-0.56%
2020โ‚น29.59 B-46.03%
2019โ‚น54.83 B21.33%
2018โ‚น45.19 B0.71%
2017โ‚น44.88 B65.54%
2016โ‚น27.11 B2.98%
2015โ‚น26.32 B75.19%
2014โ‚น15.02 B

End of Day market cap according to different sources

On May 17th, 2026 the market cap of Akebia Therapeutics was reported to be:

โ‚น27.39 Billion
by Nasdaq info icon info icon
โ‚น27.39 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚น53.089 T 203,287.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น27.417 T 104,938.39%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
โ‚น16.875 T 64,552.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
โ‚น222.73 B 753.31%๐Ÿ‡บ๐Ÿ‡ธ USA